pharmaphorum

OCTOBER 7, 2021

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.

Vaccination 98

Vaccination Vaccine Manufacturing Packaging 98

XTalks

MAY 27, 2021

To help boost production of its COVID-19 vaccine, Moderna has enlisted the services of Samsung Biologics , a contract development and manufacturing organization (CDMO) based in South Korea. The vaccine doses are intended for countries outside the US, with manufacturing planned to commence in the third quarter of 2021.

Manufacturing 98

Manufacturing Vaccination Vaccine Production 98

pharmaphorum

NOVEMBER 26, 2020

The UK’s pharma industry trade body has warned that Brexit could derail the government’s efforts to get coronavirus vaccines to the population, but welcomed other measures in this week’s spending review aimed at reviving the economy after the pandemic.

Vaccination 105

Vaccination Vaccine Life Science Regulation 105

XTalks

NOVEMBER 23, 2021

Canadian pharma and biotech contract development and manufacturing organization (CDMO) Biovectra has announced plans for building one of the first state-of-the-art mRNA vaccine and biomanufacturing facilities in Canada. Additional production would be performed at other facilities for final packaging. million, respectively.

Manufacturing 98

Manufacturing Vaccination Vaccine Drugs 98

Pharma in Brief

DECEMBER 3, 2020

Any authorization for drugs, vaccines, and medical devices issued pursuant to the interim orders are also set to terminate when the respective interim order expires or is withdrawn. Drugs and Vaccines. Both interim orders are set to expire 1 year after they were issued, or sooner if withdrawn by the Minister.

Vaccination 98

Vaccination Vaccine Drugs Manufacturing 98

Pharmaceutical Technology

SEPTEMBER 8, 2022

The list includes providers of development services, biologics management supply chain solutions, clinical trial services, commercial and logistics services, as well as packaging, labelling and distributing services for biologics.

Gene 100

Gene Marketing Vaccination Vaccine 100

BioPharma Reporter

JANUARY 28, 2022

Contract development and manufacturing organization (CDMO), Recipharm, says it has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France.

Packaging 52

Packaging Packaging Vaccination Vaccine 52

BioTech 365

JUNE 1, 2021

$15 Billion Vaccine Storage & Packaging Market – Global Size, Share, Outlook, and Opportunity Analysis to 2027 – ResearchAndMarkets.com $15 Billion Vaccine Storage & Packaging Market – Global Size, Share, Outlook, and Opportunity Analysis to 2027 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The … (..)

Packaging 40

Packaging Packaging Vaccination Vaccine 40

XTalks

OCTOBER 25, 2023

The US Food and Drug Administration (FDA) has accepted AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. FluMist has been in the market since 2003 and is the only intranasal spray vaccine option against flu.

Vaccination 59

Vaccination Vaccine Sales Pharmacy 59

BioTech 365

JANUARY 13, 2022

COVID-19 Vaccine Packaging and Delivery Devices Market Share, Trends, Industry Analysis and Segment Forecasts 2021 – 2028 – ResearchAndMarkets.com COVID-19 Vaccine Packaging and Delivery Devices Market Share, Trends, Industry Analysis and Segment Forecasts 2021 – 2028 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)

Packaging 40

Packaging Packaging Vaccination Vaccine 40

BioTech 365

NOVEMBER 26, 2020

Global Pharmaceutical Packaging Equipment Market 2020-2027: Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand – ResearchAndMarkets.com Global Pharmaceutical Packaging Equipment Market 2020-2027: Unprecedented Global Push to Expedite COVID-19 Vaccine Development to Spur Demand – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)

Packaging 40

Packaging Packaging Vaccination Vaccine 40

BioPharma Reporter

MARCH 9, 2021

Baxter BioPharma Solutions will provide fill/finish sterile manufacturing services and supply packaging for approximately 60-90 million doses of Modernaâs COVID-19 vaccine this year.

Vaccination 52

Vaccination Vaccine Packaging Packaging 52

BioTech 365

APRIL 15, 2021

Global Vaccine Storage and Packaging Market is Estimated to Account for US$ 15 Bn by End of 2027, Says Coherent Market Insights (CMI) Global Vaccine Storage and Packaging Market is Estimated to Account for US$ 15 Bn by End of 2027, Says … Continue reading →

Packaging 40

Packaging Packaging Marketing Vaccination 40

The Pharma Data

MAY 3, 2021

The European Medicines Agency (EMA) is evaluating an application submitted by Pfizer and BioNTech for use of their COVID-19 vaccine in children aged 12 to 15 years. . The vaccine has been authorized by the EU for use in people 16 years and up since December 2020. . Pfizer also shared antibody responses from the younger age group.

Vaccination 52

Vaccination Vaccine Antibody RNA 52

XTalks

FEBRUARY 11, 2021

Amidst growing global shortages of COVID-19 vaccine supplies, inaugural (by way of authorizations/approvals) COVID-19 vaccine maker Pfizer is addressing the issue by working to cut the manufacturing time of its vaccine by almost half. Related: Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production.

Manufacturing 52

Manufacturing Vaccination Vaccine DNA 52

Pfizer

APRIL 26, 2023

But the underlying question is always the same: How will Pfizer and BioNTech ensure a seamless distribution of our vaccine? With the pandemic still raging, our vaccine will be in high demand and, upon authorization or approval, rapidly utilized to help beat back the virus. In the U.S.,

Vaccination 52

Vaccination Vaccine Manufacturing Containment 52

Pfizer

APRIL 14, 2023

Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines kimkevin Fri, 04/14/2023 - 15:38 Albert Bourla On Ensuring Equitable Access to COVID-19 Vaccines Friday, January 22, 2021 - 11:21am Share We have crossed another milestone in the fight against COVID-19.

Vaccination 52

Vaccination Vaccine Development Manufacturing 52

The Pharma Data

NOVEMBER 22, 2020

As the Pfizer and BioNTech COVID-19 vaccine goes to regulators and the Moderna vaccine approaches the end of its Phase III trials, AstraZeneca and the University of Oxford announced high-level results from an interim analysis of their COVID-19 vaccine, AZD1222. The combined analysis showed average efficacy of 70%.

Vaccination 52

Vaccination Vaccine Protein Genetics 52

The Pharma Data

AUGUST 24, 2020

China is set to move ahead with human testing of a potential coronavirus vaccine that has been created using insect cells. It is hoped that using insect cells to grow proteins for the vaccine could speed up large-scale production. These were primarily border officials and health workers. Conor Kavanagh. Source link.

Vaccination 40

Vaccination Vaccine Clinical Trials Clinical Trials 40

BioTech 365

SEPTEMBER 8, 2020

MAINZ, Germany–(BUSINESS WIRE)–In 2019, SCHOTT announced a $1 billion investment in its pharmaceutical packaging business to expand capacity by more than 50 percent. Now, SCHOTT has achieved a milestone, delivering vials to three out of every four COVID-19 vaccine projects … Continue reading →

Vaccination 40

Vaccination Vaccine Packaging Packaging 40

The Pharma Data

OCTOBER 30, 2020

Takeda and Moderna join forces to expand Covid-19 vaccine supply in Japan. A three-way agreement between Takeda , Moderna and the Government of Japan’s Ministry of Health Labour and Welfare (MHLW) plans to bring mRNA-1273, Moderna’s Covid-19 vaccine candidate, to Japan. Source link.

FDA Approval 52

FDA Approval Vaccination Vaccine Clinical Trials 52

Roots Analysis

OCTOBER 30, 2023

The next generation RNA therapeutics and RNA vaccines pipeline currently features the presence of more than 20 circular RNA therapeutics and vaccines, being developed across initial stages of drug development (discovery and preclinical).

RNA 40

RNA Vaccination Vaccine Development 40

The Pharma Data

JUNE 25, 2021

Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% “Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines. Glenn, M.D.,

Vaccination 40

Vaccination Vaccine Trials Immune Response 40

The Pharma Data

OCTOBER 14, 2020

Study May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics. Such aptamers have the potential to identify biomarkers for protective CoV-2 immunity and may lead to accelerated precision medicine-driven vaccines designed to protect against COVID-19. CHATHAM, N.J., About TNX-1800. 1 Noyce RS, et al.

Vaccination 40

Vaccination Vaccine Development Medicine 40

The Pharma Data

MAY 14, 2021

Product Name: Package | Prasara Yoga. Click here to get Package | Prasara Yoga at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors. You will NOT receive a physical package shipped to you in the mail.

Packaging 52

Packaging Packaging Production Doctors 52

XTalks

DECEMBER 29, 2021

Bayer has announced that all of its products will have 100 percent green packaging by 2030. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or reusable in less than ten years’ time.

Packaging 59

Packaging Packaging Production Allergies 59

Roots Analysis

FEBRUARY 1, 2024

Further, the cold chain storage process involves the cold chain storage, cold chain transportation, and monitoring temperature controlled packaging products. Therefore, the pharmaceutical, biotech, food and chemical industries usually rely on cold chain packaging for the transportation of their products.

Packaging 40

Packaging Packaging Containment Production 40

Scienmag

JANUARY 8, 2021

Credit: University of Leeds Researchers have for the first time identified the way viruses like the poliovirus and the common cold virus ‘package up’ their genetic code, allowing them to infect cells.

Packaging 94

Packaging Packaging Genetics Research 94

Pharmaceutical Technology

DECEMBER 8, 2022

Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies. Tom Lenaerts is head of global process engineering for Datwyler, a leading supplier of parenteral packaging components such as stoppers and plungers. By Datwyler. United Kingdom.

Manufacturing 246

Manufacturing Packaging Packaging Production 246

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The post 7 Problems with Using Borosilicate Glass to Package Drugs appeared first on Pharma Mirror Magazine.

Packaging 130

Packaging Packaging Drugs Clinical Trials 130

STAT News

OCTOBER 27, 2022

This calls for celebration with a cup of stimulation, and we are opening a new package of Pumpkin Spice for the occasion. However, this is also shaping up as a beautiful day as well, given the clear and sunny skies — and delicious breezes — enveloping the Pharmalot campus this morning. Autumn, after all, is in full swing.

Packaging 98

Packaging Packaging Manufacturing Production 98

The Pharma Data

DECEMBER 16, 2020

Food and Drug Administration (FDA) advisory panel in regard to the COVID-19 vaccine from Moderna. The Vaccines and Related Biological Products Advisory Committee will be determining whether the product should be authorized for emergency use, according to CNBC. The vote itself is not slated to take place until after 3 p.m.

Vaccination 52

Vaccination Vaccine Immune Response FDA Approval 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Contamination 130

Contamination Packaging Packaging Manufacturing 130

The Pharma Data

JANUARY 16, 2021

16, 2021 — President-elect Joe Biden described an ambitious national vaccination plan on Friday that will deliver coronavirus vaccines to far more people and invoke a wartime law to boost vaccine production. Even if Biden invokes the Korean War-era Defense Production Act, it may take some time to ease vaccine shortages.

Vaccination 52

Vaccination Vaccine Nurses Packaging 52

Pharmaceutical Technology

AUGUST 16, 2022

Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis. Outsourcing may also be pursued if it is more favourable in terms of time and/or cost.

Gene Therapy 162

Gene Therapy Packaging Packaging Contract Packaging 162

Pharmaceutical Technology

NOVEMBER 1, 2022

Darwin is part of a package of projects and initiatives to transform to data-driven medicines regulation.”. This has included high-profile issues such as the study into reports of blood clots seen with AstraZeneca’s COVID-19 vaccine. Arlett explains that Darwin EU is playing a collaborative role in this goal.

Big Data 278

Big Data Regulation Medicine Research 278

Pharmaceutical Technology

NOVEMBER 30, 2022

These contracts involve the manufacturing of biological and small molecule active pharmaceutical ingredients (APIs), parenteral manufacturing and packaging, and other manufacturing-related tasks. Catalent has been engaged in the parenteral manufacturing and packaging of the anti-IL-4/IL-13 antibody. Regulatory decisions come in.

Manufacturing 130

Manufacturing Packaging Packaging Drugs 130